Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib may effectively treat resistant lichen planopilaris.

Omalizumab may cause hair loss.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Antifungal treatment reduced asthma exacerbations and corticosteroid use but its overall benefit is unclear.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.

More research is needed to understand and treat morphea effectively.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Apremilast showed mixed results for treating severe alopecia areata.

MPZL3 is crucial for seborrheic dermatitis development.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

The donkey had a severe disease affecting multiple organs and was euthanized.

Certain chemicals cause hair graying in black mice but not yellow mice.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Platelet-rich plasma (PRP) can significantly improve melasma, a skin pigmentation disorder, but may not add benefits when used with certain other treatments.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Promising cancer treatments were found, but the manufacturer closed.

A woman developed a scalp condition from using minoxidil, which improved with a different treatment but left scarring.

Mice with a mutated Dsg3 gene showed severe symptoms but not the typical blistering of pemphigus vulgaris.

DPK-060 in poloxamer gel effectively treats skin infections, but nanocarriers don't enhance its efficacy.